Literature DB >> 2295942

Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT.

J M Mountz1, J G Modell, N L Foster, E S DuPree, R J Ackermann, N A Petry, L E Bluemlein, D E Kuhl.   

Abstract

This study investigated the possibility that a relationship between the anatomic defects observed on computed tomography (CT) and the functional defects observed on single photon emission computed tomography (SPECT) might be used as an outcome measure to predict clinical recovery from the neurologic deficits induced by stroke. Twenty-seven patients with stroke location limited primarily to cerebral cortex were included in the study: each patient underwent a cranial CT scan, 99mTc hexamethylpropyleneamineoxime SPECT cerebral perfusion scan, and an initial and 1-yr follow-up neurologic examination. A strongly positive correlation between the ratio of the SPECT to CT volume defect sizes (SPECT divided by CT) and recovery following stroke was found, such that the greater the SPECT to CT ratio, the better the subsequent recovery of neurological deficits. Discriminant function analysis revealed that the best predictor of clinical outcome following stroke was the log-transformation of SPECT divided by CT. The results suggest that the relationship between the perfusion defects and tissue loss measured by SPECT and CT imaging may have prognostic utility following stroke limited primarily to cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295942

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

Review 1.  Clinical, radiological, and functional evaluation following acute stroke.

Authors:  D G Grosset
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  SPECT and rehabilitation: which role?

Authors:  U P Guerra
Journal:  Ital J Neurol Sci       Date:  1998-10

3.  Effects of non-linear flow and spatial orientation on technetium-99m hexamethylpropylene amine oxime single-photon emission tomography.

Authors:  S J Stapleton; C B Caldwell; L E Ehrlich; C L Leonhardt; S E Black; M J Yaffe
Journal:  Eur J Nucl Med       Date:  1995-09

4.  Comparison of mean cerebral transit time and single-photon emission tomography for estimation of stroke outcome.

Authors:  K R Lees; C J Weir; G J Gillen; A K Taylor; C Ritchie
Journal:  Eur J Nucl Med       Date:  1995-11

5.  Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.

Authors:  R A Dierckx; A Dobbeleir; B A Pickut; L Timmermans; I Dierckx; A Vervaet; J Vandevivere; W Deberdt; P P De Deyn
Journal:  Eur J Nucl Med       Date:  1995-05

6.  Application of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography to neurologic prognosis in patients undergoing urgent carotid surgery.

Authors:  I Y Shvera; A M Cherniavsky; W Y Ussov; M P Plotnikov; A A Sokolov; V M Shipulin; V I Chernov
Journal:  Eur J Nucl Med       Date:  1995-02

7.  Signs of cerebral atrophy on single-photon emission tomography.

Authors:  C O Wong; G E Meyerrose; S Sostre
Journal:  Eur J Nucl Med       Date:  1994-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.